Procurement for Empowerment: The Impact of Female Decision-Makers in Reproductive Health Supply Chains
研究发现在中低收入国家，女性卫生部长与避孕药具采购量平均增加66%相关，且女性议员比例越高，这种效应越强，表明女性决策者更关注女性健康议题。
Access to contraceptives empowers women to not only exercise their reproductive rights and avert unintended pregnancies, but also to prevent a spectrum of adverse societal and health outcomes (e.g., unfulfilled career aspirations, unsafe abortions, maternal deaths.) However, in low- and middle-income countries (LMICs), where resources are limited and women are under-represented as decision-makers in national governments, reproductive health has not traditionally been prioritized. Motivated by past research showing that female decision-makers tend to prioritize issues in ways that align more closely with women's needs and preferences, we examine the relationship between female decision-makers in national governments and contraceptive procurement. Specifically, we focus on female decision-makers at two levels, as health ministers and parliamentarians, and examine their impact on the procurement quantity of contraceptives by LMICs. Our empirical analysis, based on a comprehensive compilation of data across six distinct sources, shows that a female (vs. male) health minister is associated with an average 66% increase in the procurement quantity of contraceptives. Notably, this relationship is strengthened with an increase in the proportion of female representatives in national parliaments. Together, these findings demonstrate that female (vs. male) decision-makers exhibit greater commitment to contraceptive procurement, an issue that has a disproportionate impact on women's health and well-being. As ensuring good health and well-being for all and increasing gender parity in leadership positions are two of the key United Nations Sustainable Development Goals, our study on examining the relationship between female decision-makers and contraceptive procurement constitutes a timely and consequential line of inquiry.